SITI WEB ITALIA

CATALOGARE

Informazioni sul dominio e sul sito Web:

permax.it



English

Informazioni sul sito:


Nome del dominio - permax.it


Titolo del sito - Permax – Forniture per laboratori scientifici


Vai al sito web - Permax – Forniture per laboratori scientifici



Le parole migliori contano permax.it:

per - 13
laboratori - 7
permax - 7
prodotti - 7
strumentazione - 6
linea - 6
scientifici - 5
vetro - 5
scopri - 5
migliore - 4

Vedi l'elenco completo delle parole



Posizione GEO del sito


Posizione Paese - Italy



Fornitore - Server Plan S.r.l.




permax.it Posizione GEO sulla mappa


Site Logo



There is no Open Graph data at permax.it




Informazioni per il dominio permax.it


indirizzo IP:


77.39.212.161


Server dei nomi di dominio:


ns2.nomeasy.com ns1.nomeasy.com


Tutti i record:


☆ permax.it. 3594 IN MX 0 permax-it.mail.protection.outlook.com.
☆ permax.it. 21594 IN NS ns2.nomeasy.com.
☆ permax.it. 594 IN A 77.39.212.161
☆ permax.it. 3594 IN TXT "MS=ms81706921"
☆ permax.it. 3594 IN TXT "v=spf1 include:spf.protection.outlook.com include:turbo-smtp.com -all"
☆ permax.it. 21594 IN NS ns1.nomeasy.com.
☆ permax.it. 21594 IN SOA ns1.nomeasy.com. postmaster.permax.it. 2023112816 14400 3600 1209600 86400


Informazioni sul server Whois per permax.it



Brief facts about permax:

Pergolide, sold under the brand name Permax and Prascend among others, is an ergoline-based dopamine receptor agonist used in some countries for the treatment of Parkinson's disease. Parkinson's disease is associated with reduced dopamine activity in the substantia nigra of the brain. Pergolide acts on many of the same receptors as dopamine to increase receptor activity. It was patented in 1978 and approved for medical use in 1989. In 2007, pergolide was withdrawn from the U.S. market for human use after several published studies revealed a link between the drug and increased rates of valvular heart disease. However, a veterinary form of pergolide, marketed under the trade name Prascend, is permitted for the treatment of pituitary pars intermedia dysfunction also known as equine Cushing's syndrome in horses.

Ergolines

D2-receptor agonists

Equine medications

Thioethers

Withdrawn drugs

 

© DMS 2011-